COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the return of raised funds

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-036

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on the return of raised funds

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 

Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) deliberated and approved the “Proposal on Temporarily Replenishing Working Capital with Partial Idle Raised Funds” at the first meeting of the fifth board of directors held on May 28, 2013. The company agreed to use the 40 million yuan idle raised funds to temporarily replenish the working capital for a period of no more than four months, from May 29, 2013 to September 28, 2013. For details of the use of some of the idle raised funds to temporarily supplement the working capital, please refer to the “Securities Times”, “China Securities Journal”, “Shanghai Securities News”, “Securities Daily” and www.cninfo.com.cn on May 29, 2013. .cninfo.com.cn) “Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on Temporary Replenishment of Working Capital with Partial Idle Raised Funds” (2013-025).

 

On September 26, 2013, the company repatriated the above-mentioned funds raised from the temporary replenishment of working capital of 40 million yuan to the fundraising account, and the use period was less than 4 months. The company has notified the sponsor institution Northeast Securities Co., Ltd. and the sponsor representative of the return of the above raised funds.

 

Special announcement

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

September 27, 2013